Your session is about to expire
← Back to Search
Flax "milk" for Cardiotoxicity (CANFLAX Trial)
CANFLAX Trial Summary
This trial is examining the use of flaxseed to prevent heart failure in women with breast cancer who are also receiving treatment with doxorubicin and trastuzumab.
CANFLAX Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCANFLAX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CANFLAX Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research endeavor currently enrolling participants?
"Affirmative, the information hosted on clinicaltrials.gov indicates that this medical trial is presently recruiting individuals to take part in it. It was initially posted on October 21st 2020 and recently updated on November 11th 2020. Sixty people must be enrolled across a single site for the study's completion."
To what extent is the population of this experiment increasing?
"Affirmative. The information available on clinicaltrials.gov indicates that this medical experiment is actively seeking participants, having been posted on October 21st 2020 and last updated November 11th 2020. 60 patients must be recruited from a single site to complete the trial requirements."
Share this study with friends
Copy Link
Messenger